Jason Tardio
Chief Operating Officer at OVID THERAPEUTICS INC.
Net worth: 85 781 $ as of 2024-03-30
Profile
Jason Tardio's career history includes current and former positions as well as his education.
Currently, he is the Chief Operating Officer at Ovid Therapeutics, Inc. Prior to this, he held the position of General Manager & MD-Latin America South at Biogen, Inc. from 2017 to 2018.
He also served as the VP & Head-Multiple Sclerosis Franchise at Novartis, Inc. in 2019.
In terms of education, Mr. Tardio obtained an undergraduate degree from The College of New Jersey and an MBA from St. Joseph's University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
OVID THERAPEUTICS INC.
0.04% | 2024-02-21 | 28,125 ( 0.04% ) | 85 781 $ | 2024-03-30 |
Jason Tardio active positions
Companies | Position | Start |
---|---|---|
OVID THERAPEUTICS INC. | Chief Operating Officer | 2021-07-07 |
Former positions of Jason Tardio
Companies | Position | End |
---|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Corporate Officer/Principal | 2019-10-31 |
BIOGEN INC. | Corporate Officer/Principal | 2018-08-31 |
Training of Jason Tardio
The College of New Jersey | Undergraduate Degree |
St. Joseph's University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
BIOGEN INC. | Health Technology |
OVID THERAPEUTICS INC. | Health Technology |
Private companies | 1 |
---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Health Technology |
- Stock Market
- Insiders
- Jason Tardio